Skip to content

Electronic Strategies for Tailored Exercise to Prevent FallS

Electronic Strategies for Tailored Exercise to Prevent FallS

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04993781
Acronym
eSTEPS
Enrollment
11945
Registered
2021-08-06
Start date
2023-06-08
Completion date
2025-08-31
Last updated
2026-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise Self-Efficacy, Fall Injury, Falls, Falls Self-Efficacy

Brief summary

The objectives of this proposal are to evaluate the eSTEPS CDS (eSTEPS) in a cluster randomized controlled trial. The intervention includes the following: 1) A machine learning-based fall injury risk screening algorithm to improve traditional fall risk screening. 2) Provider BPA and/or Care Gap and Smart Set to provide CDS that helps primary care providers develop a tailored fall prevention exercise plan in the context of a Medicare Wellness Visit and 3) eSTEPS Patient App and exercise tools to provide older patients continued access to their interactive, tailored exercise plan.

Detailed description

This project will use traditional fall risk screening and machine learning approaches to accurately identify older adults at risk for falls. Investigators will then develop CDS that will be implemented into the electronic health record that helps primary care providers and older patients develop a tailored fall prevention exercise plan (eSTEPS). The eSTEPS CDS will be integrated into the widely implemented Epic EHR which will be accessible through the Care Gap and SmartSet to provide actionable CDS within primary care clinic workflows and facilitate the use of CDS with older patients during their annual wellness visit, ensuring that evidence-based recommendations are tailored to patients' preferences. The tailored exercise prescription will also be available through printouts, a website, and an app for use by patients at home. The eSTEPS intervention includes the provider CDS and the patient resources (printouts, website, exercise app) that will support primary care providers and patients with personalized exercise care planning during an annual Medicare Wellness visit. Investigators will conduct a cluster randomized controlled trial in urban primary care clinics to test the efficacy of the eSTEPS CDS intervention. Development of the eSTEPS CDS within the widely adopted Epic Electronic Health Record will support dissemination of evidence for older adults.

Interventions

BEHAVIORALeSTEPS CDS

Primary care clinics at Brigham and Women's Hospital will be randomized to receive the eSTEPS CDS or usual care. The University of Texas Medical Branch (UTMB) will be the replication site, with all participating primary care practices receiving the eSTEPS CDS.

Sponsors

Brigham and Women's Hospital
Lead SponsorOTHER
National Institute on Aging (NIA)
CollaboratorNIH
National Institutes of Health (NIH)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

The design is a cluster randomized, parallel group superiority trial with practices stratified by healthcare system and patients nested within practices. The unit of randomization is the practice.

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

In order to be eligible to participate in this study, an individual must meet all of the following criteria: * Age 65 or above * Patients enrolled in participating primary care intervention and control practices at MGB or enrolled in participating primary care replication trial intervention practices at UTMB * Positive screen for fall risk at annual wellness visit

Exclusion criteria

An individual who meets any of the following criteria will be excluded from participation in this study: \- Not community-dwelling (i.e. residents of long-term care facilities, prisoners etc.) Enrollment in the Subsample for Patient Reported Outcomes (PROs): A subsample of patients will be recruited and consented to participate in follow-up phone calls and surveys. Additional

Design outcomes

Primary

MeasureTime frameDescription
To Determine the Effect of the eSTEPS Intervention on the Rate of FallsUp to 23 monthsTo determine the effect of the eSTEPS intervention on all falls per 100 patient years

Secondary

MeasureTime frameDescription
To Determine the Effect of the eSTEPS Intervention on Falls Self-efficacy (Fear of Falling)Change from initial assessment to 6 monthsFalls self-efficacy (fear of falling) will be measured using the Modified Falls Efficacy Scale (mFES). This scale assesses confidence with completing a list of activities without falling and contains 14 items each measured on a scale of 0 to 10. 0 means "not confident at all", 5 means "fairly confident", and 10 means "completely confident." he total score is the average of all of the item scores and ranges from zero to ten. A higher score reflects more confidence and less fear of falling. Participants are classified as either fearful (MFES score \< 8) or not fearful (MFES greater than or equal to 8). The total score range is 0 to 10.
To Determine the Effect of the eSTEPS Intervention on Self-efficacy for ExerciseChange from initial visit to 6 monthsSelf-efficacy for exercise will be measured using the Self-Efficacy for Exercise (SEE) Scale. This scale consists of nine situations that may affect participation in exercise and ask participants to describe their current level of confidence that they could exercise 3 times a week for 20 minutes each time. 0 means "not confident", 5 means "fairly confident", and 10 means "very confident." The total score for the SEE scale is calculated by taking the numerical ratings for each statement and dividing by number of responses. The score indicates the strength of self-efficacy for exercise expectations. The higher the average score, the greater the participant's self-efficacy for exercise. The total score range is 0 to 10.

Countries

United States

Baseline characteristics

Characteristic
Age, Continuous76.7 Years
STANDARD_DEVIATION 7.5
Ethnicity (NIH/OMB)
Hispanic or Latino
1047 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
10423 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
261 Participants
Falls Self-efficacy (fear of falling)8.7 Score
STANDARD_DEVIATION 1.5
Race/Ethnicity, Customized
Black/African American
360 Participants
Race/Ethnicity, Customized
Missing
613 Participants
Race/Ethnicity, Customized
Other
131 Participants
Race/Ethnicity, Customized
White
9428 Participants
Self-efficacy for exercise7.3 Score
STANDARD_DEVIATION 2.2
Sex: Female, Male
Female
3853 Participants
Sex: Female, Male
Male
2073 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
433 / 5,681402 / 6,264
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
1,767 / 5,6811,787 / 6,264

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 9, 2026